Cargando…
Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten
The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vacc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364213/ https://www.ncbi.nlm.nih.gov/pubmed/22666501 http://dx.doi.org/10.1371/journal.pone.0038329 |
_version_ | 1782234506900537344 |
---|---|
author | Schellenberger, Mario T. Grova, Nathalie Farinelle, Sophie Willième, Stéphanie Revets, Dominique Muller, Claude P. |
author_facet | Schellenberger, Mario T. Grova, Nathalie Farinelle, Sophie Willième, Stéphanie Revets, Dominique Muller, Claude P. |
author_sort | Schellenberger, Mario T. |
collection | PubMed |
description | The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vaccine to induce B[a]P specific antibodies (Grova et al., Vaccine. 2009;27:4142–51). Here, we investigated in mice the efficacy of B[a]P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a]P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a]P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a]P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a]P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a]P and B[a]P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a]P in the blood and modulate its faecal excretion (15–56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a]P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a pre-existing immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a]P are warranted. |
format | Online Article Text |
id | pubmed-3364213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33642132012-06-04 Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten Schellenberger, Mario T. Grova, Nathalie Farinelle, Sophie Willième, Stéphanie Revets, Dominique Muller, Claude P. PLoS One Research Article The prototype polycyclic aromatic hydrocarbon benzo[a]pyrene (B[a]P) is an environmental pollutant and food contaminant of epidemiological importance. To protect against adverse effects of this ubiquitous carcinogen, we developed an immunoprophylactic strategy based on a B[a]P-protein conjugate vaccine to induce B[a]P specific antibodies (Grova et al., Vaccine. 2009;27:4142–51). Here, we investigated in mice the efficacy of B[a]P-peptide conjugates based on promiscuous T cell epitopes (TCE) into further improve this approach. We showed that B[a]P-peptide conjugates induced very different levels of hapten-specific antibodies with variable functional efficacy, depending on the carrier. In some cases peptide carriers induced a more efficient antibody response against B[a]P than tetanus toxoid as a protein carrier, with the capacity to sequester more B[a]P in the blood. Reducing the carrier size to a single TCE can dramatically shift the antibody bias from the carrier to the B[a]P. Conjugates based on the TCE FIGITEL induced the best anti-hapten response and no antibodies against the carrier peptide. Some peptide conjugates increased the selectivity of the antibodies for the activated metabolite 7,8-diol-B[a]P and B[a]P by one or two orders of magnitude. The antibody efficacy was also demonstrated in their ability to sequester B[a]P in the blood and modulate its faecal excretion (15–56%). We further showed that pre-existing immunity to the carrier from which the TCE was derived did not reduce the immunogenicity of the peptide conjugate. In conclusion, we showed that a vaccination against B[a]P using promiscuous TCEs of tetanus toxin as carriers is feasible even in case of a pre-existing immunity to the toxoid and that some TCE epitopes dramatically redirect the antibody response to the hapten. Further studies to demonstrate a long-term protection of an immunoprophylactic immunisation against B[a]P are warranted. Public Library of Science 2012-05-30 /pmc/articles/PMC3364213/ /pubmed/22666501 http://dx.doi.org/10.1371/journal.pone.0038329 Text en Schellenberger et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Schellenberger, Mario T. Grova, Nathalie Farinelle, Sophie Willième, Stéphanie Revets, Dominique Muller, Claude P. Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title | Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title_full | Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title_fullStr | Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title_full_unstemmed | Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title_short | Immunogenicity of a Promiscuous T Cell Epitope Peptide Based Conjugate Vaccine against Benzo[a]pyrene: Redirecting Antibodies to the Hapten |
title_sort | immunogenicity of a promiscuous t cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the hapten |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364213/ https://www.ncbi.nlm.nih.gov/pubmed/22666501 http://dx.doi.org/10.1371/journal.pone.0038329 |
work_keys_str_mv | AT schellenbergermariot immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten AT grovanathalie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten AT farinellesophie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten AT williemestephanie immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten AT revetsdominique immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten AT mullerclaudep immunogenicityofapromiscuoustcellepitopepeptidebasedconjugatevaccineagainstbenzoapyreneredirectingantibodiestothehapten |